Machine Learning Estimation of Low-Density Lipoprotein Cholesterol in Women With and Without HIV. (1st March 2022)

• Record Type: Journal Article
• Authors: Dong, Tony; Rana, Mariam N.; Longenecker, Chris T.; Rajagopalan, Sanjay; Kim, Chang H.; Al-Kindi, Sadeer G.
• Is Part Of: Journal of acquired immune deficiency syndromes. Volume 89:Number 3(2022)
• Publication Date: 2022-03-01
• Subjects: low-density lipoprotein -- human immunodeficiency virus -- measurement/estimation -- machine learning -- support vector machine; AIDS (Disease) -- Periodicals; Acquired Immunodeficiency Syndrome -- Periodicals; AIDS (Disease); Periodicals; 616.9792005
• DOI: 10.1097/QAI.0000000000002869
• Languages: English
• ISSNs: 1525-4135

Abstract

Abstract : Introduction: Low-density lipoprotein cholesterol (LDL-C) is typically estimated from total cholesterol, high-density lipoprotein cholesterol, and triglycerides. The Friedewald, Martin–Hopkins, and National Institutes of Health equations are widely used but may estimate LDL-C inaccurately in certain patient populations, such as those with HIV. We sought to investigate the utility of machine learning for LDL-C estimation in a large cohort of women with and without HIV. Methods: We identified 7397 direct LDL-C measurements (5219 from HIV-infected individuals, 2127 from uninfected controls, and 51 from seroconvertors) from 2414 participants (age 39.4 ± 9.3 years) in the Women's Interagency HIV Study and estimated LDL-C using the Friedewald, Martin–Hopkins, and National Institutes of Health equations. We also optimized 5 machine learning methods [linear regression, random forest, gradient boosting, support vector machine (SVM), and neural network] using 80% of the data (training set). We compared the performance of each method using root mean square error, mean absolute error, and coefficient of determination (R 2 ) in the holdout (20%) set. Results: SVM outperformed all 3 existing equations and other machine learning methods, achieving the lowest root mean square error and mean absolute error, and the highest R 2 (11.79 and 7.98 mg/dL, 0.87, respectively, compared with those obtained using the Friedewald equation: 12.45 and 9.14 mg/dL, 0.87). SVM performance remained superior in subgroups with and without HIV, with nonfasting measurements, in LDL <70 mg/dL and triglycerides > 400 mg/dL. Conclusions: In this proof-of-concept study, SVM is a robust method that predicts directly measured LDL-C more accurately than clinically used methods in women with and without HIV. Further studies should explore the utility in broader populations. Abstract : Supplemental Digital Content is Available in the Text.